The new firm promises to bring a new model for a consulting partner in the life sciences industry. NEW YORK,…
New Appointments Underscore Commitment to Driving Innovation and Industry-Leading GrowthLAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer,…
Includes initial funding of approximately $20 million, as well as the potential for additional proceeds of approximately $20 million from…
- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and…
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or…
Significant POLB 001 Patent Granted in United StatesImmunomodulator II patent grant further strengthens robust intellectual property portfolio for partnering LONDON,…
$25 million funded at close; up to $25 million of additional capital available at the Company’s option, based on the…
NASHVILLE, Tenn.--(BUSINESS WIRE)--Reimagine Care, the nation’s leading provider of virtual-first cancer care, proudly announces the expansion of its esteemed Clinical…
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release…
FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of…